Strategic Focus and Financial Resilience: Terence Flynn’s Positive Outlook on Intellia Therapeutics
Analyst Terence Flynn of Morgan Stanley maintained a Buy rating on Intellia Therapeutics (NTLA – Research Report), retaining the price target ...
24/7 Wall St3h
Retirees: 5 Income-Generating ETFs to Boost Your Monthly Cash Flow
These are some of the top income-generating ETFs to help you retire sooner and generate cash flow from your capital.
pharmaphorum22h
FDA gives AbbVie's c-Met lung cancer ADC a breakthrough tag
The FDA thinks an antibody-drug conjugate (ADC) developed by AbbVie could set new standards in treatment for certain patients with lung cancer, awarding the drug breakthrough status. Teliso-V ...
centerforbiosimilars10h
Eye on Pharma: Korean Drugmakers’ Impact in Europe; New Denosumab, Eculizumab Deals
Korean drugmakers hold over 50% market share in the 6 best-selling biosimilar markets, 2 companies sign exclusive licensing ...